Oxidative stress in severe pulmonary hypertension.
暂无分享,去创建一个
N. Voelkel | R. Murphy | R. Tuder | S. Flores | C. Cool | Matthew W Hopken | R. Bowers | Matthew W. Hopken
[1] S. Hazen,et al. Oxidative and nitrosative events in asthma. , 2003, Free radical biology & medicine.
[2] N. Voelkel,et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. , 2003, American journal of respiratory cell and molecular biology.
[3] H. Kasai. Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis. , 2002, Free radical biology & medicine.
[4] R. Hotchkiss,et al. Myeloperoxidase produces nitrating oxidants in vivo. , 2002, The Journal of clinical investigation.
[5] J. K. Hurst. Whence nitrotyrosine? , 2002, The Journal of clinical investigation.
[6] D. Bullard,et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. , 2001, The Journal of clinical investigation.
[7] G. Semenza,et al. Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.
[8] J. Cracowski,et al. Increased lipid peroxidation in patients with pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.
[9] J. Davis,et al. Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.
[10] H. Niedermüller,et al. Levels of 8-hydroxy-2′-deoxyguanosine in cellular DNA from 12 tissues of young and old Sprague–Dawley rats , 2001, Experimental Gerontology.
[11] N. Voelkel,et al. Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. , 2001, The European respiratory journal.
[12] N. Voelkel,et al. Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. , 2001, Journal of applied physiology.
[13] N. Voelkel,et al. Gene Expression Patterns in the Lungs of Patients With Primary Pulmonary Hypertension: A Gene Microarray Analysis , 2001, Circulation research.
[14] Elias S. J. Arnér,et al. Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.
[15] R. Murphy,et al. A Novel Glutathione Containing Eicosanoid (FOG7) Chemotactic for Human Granulocytes* , 2000, The Journal of Biological Chemistry.
[16] David S. McClintock,et al. Role of Oxidants in NF-κB Activation and TNF-α Gene Transcription Induced by Hypoxia and Endotoxin1 , 2000, The Journal of Immunology.
[17] N. Chandel,et al. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. , 2000, Journal of immunology.
[18] C. Kunsch,et al. Oxidative stress as a regulator of gene expression in the vasculature. , 1999, Circulation research.
[19] A. Al-Mehdi,et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. , 1998, Circulation research.
[20] A. Arroliga,et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[21] R. Murphy,et al. Activation of human polymorphonuclear leukocytes by products derived from the peroxidation of human red blood cell membranes. , 1998, Chemical research in toxicology.
[22] N. Voelkel,et al. Pulmonary hypertension and inflammation. , 1998, The Journal of laboratory and clinical medicine.
[23] M. Humbert,et al. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[24] N. Voelkel,et al. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[25] G. FitzGerald,et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. , 1997, The Journal of clinical investigation.
[26] W. Powell,et al. Effects of 5-oxo-6,8,11,14-eicosatetraenoic acid on expression of CD11b, actin polymerization, and adherence in human neutrophils. , 1997, Journal of immunology.
[27] W. Glasgow,et al. Mammalian arachidonate 12-lipoxygenases. , 1997, Advances in experimental medicine and biology.
[28] R. J. Waugh,et al. Mass spectrometric analysis of four regioisomers of F2-isoprostanes formed by free radical oxidation of arachidonic acid , 1996, Journal of the American Society for Mass Spectrometry.
[29] E. Stadtman,et al. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] O. Rådmark. Arachidonate 5-lipoxygenase. , 2002, Journal of lipid mediators and cell signalling.
[31] M. Humbert,et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[32] S. Matalon,et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. , 1994, The Journal of clinical investigation.
[33] T. Higenbottam,et al. Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity. , 1994, QJM : monthly journal of the Association of Physicians.
[34] K. Schulze-Osthoff,et al. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] J S Beckman,et al. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. , 1993, Biochemical Society transactions.
[36] A. Wendel,et al. Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. , 1993, The Journal of biological chemistry.
[37] W. Leonard,et al. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Morrow,et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Freeman,et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.